key: cord-0917397-1povlzsv
authors: Boucher, Barbara J
title: Adjustments in analyses of vitamin D status, allowing for vitamin D determinants, for Covid‐19 risks
date: 2020-06-26
journal: Diabetes Metab Res Rev
DOI: 10.1002/dmrr.3375
sha: 101a4fd911facc3406622dc5d94bd68f13201076
doc_id: 917397
cord_uid: 1povlzsv

nan

Tel: -07899 846 309

Emerging data suggests vitamin D inadequacy, most common in dark-skinned Britons, is associated with increased severity and mortality of Covid-19 infections, observationally. [1] Prospectively, UK Biobank data analyses report no association. [2] However, vitamin D has effects that should reduce Covid-19 risks, increasing secretion of anti-bacterial/antiviral compounds [cathelicidin and defensins], reducing progression of protective to destructive inflammation by suppressing pro-inflammatory and stimulating anti-inflammatory cytokine production and increasing lung ACE2 production, recognised protective effect as noted by Grant et al. [2] Observationally, vitamin D status [serum 25(OH)D concentration] may fall in covid19 infections [reverse confounding]. Prospectively, assessments of vitamin D status as a predictor of Covid-19 risks in Black, Asian and Ethnic Minority [BAME] groups requires recognition of differences between people, and peoples, that directly affect serum 25(OH)D concentrations.

Serum 25(OH)D values are not simply related to available vitamin D through constitutive expression of the specific hepatic 25-hyroxylase enzyme since obesity reduces that enzymes expression, lowering serum 25(OH)D values, and explaining the x2-3 fold greater vitamin D intakes needed in obesity vs. non-obesity to achieve comparable rises in serum 25(OH)D. [3] Skin synthesis of vitamin D is reduced by dark-skin since melanin is an effective sunscreen and dark-skinned populations are well-known to have greater rates of vitamin D deficiency in northern latitudes than pale-skinned people, needing greater exposure to UVB to achieve comparable improvements in vitamin D status to those in people with pale skin,] these factors strongly support the comments of Grant el al. [4] Obesity and BAME ethnicity, currently considered major risk factors for increased Covid-19 severity, both reduce serum 25(OH)D directly. Thus, analyses of low vitamin D status as a potential casual factor for health risks should not be adjusted for those factors, to avoid confounding. Instead, analyses of vitamin D status in prediction of covid-19 risks could be made separately for different ethnic groups [2] and also for obese and non-obese subjects within those groups. Clearly, therefore, the UK-Biobank analyses in question cannot be taken to be definitive in excluding vitamin D status as a predictor of Covid-19 risks in either dark, or pale, skinned subjects. [2] This is important because if deficiency of Vitamin increases covid-19 risks, then eliminating UK deficiency nationally would provide costeffective protection against Covid-19. It would also eliminate a multi-generational inequality in vitamin D status between BAME and non-BAME Britons [5] thereby contributing to the aims of the recently announced review on British ethnic inequalities.

https://www.theguardian.com/world/2020/apr/16/inquiry-disproportionate...

Patterns of COVID-19 mortality and vitamin D: an Indonesian study. Coronavirus & Infectious Disease Research eJournal

Vitamin D concentrations and COVID-19 infection in UK Biobank

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths

Vitamin D Metabolism Revised: Fall of Dogmas

The English disease" or "Asian rickets"? Medical responses to postcolonial immigration